Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Skin & Wound Healing

Photobiomodulation: A Systematic Review of the Oncologic Safety of Low-Level Light Therapy for Aesthetic Skin Rejuvenation

There are no relevant clinical trial data linking PBM with any significant adverse events, including the finding of a new or recurrent malignancy.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors reviewed clinical trial safety data along with in vitro and in vivo studies to assess whether photobiomodulation for aesthetic skin rejuvenation is oncologically safe. They report that red and near infrared light mainly enhanced healthy cell proliferation and reduced neoplastic cell proliferation or viability, that in vivo tumor results were varied, and that no relevant clinical trial data linked the treatment to new or recurrent malignancy. The authors conclude it appears oncologically safe, though evidence is limited.

Who or what was studied
unclear
Limits stated in the abstract
The abstract reports mixed in vitro and in vivo results, equivocal invasiveness findings, and in vivo tumor results with no clear pattern, and it does not state study counts or participant numbers.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

Photobiomodulation (PBM) therapy is an increasingly popular modality for aesthetic skin rejuvenation. PBM induces genomic, proteomic, and metabolomic processes within target cells, but such manipulation of cell behavior has led to concerns about oncologic safety. This article presents a summary of the clinical and preclinical evidence for the oncologic safety of PBM for aesthetic skin rejuvenation. A focused systematic review was performed, in which safety data from clinical trials of PBM for skin rejuvenation was supplemented by analyses of in vitro data obtained from cells derived from human skin and human neoplastic cells and in vivo data of tumors of the skin, oral cavity, and breast. Within established parameters, red and near infrared light mainly enhances proliferation of healthy cells without a clear pattern of influence on cell viability. The same light parameters mainly reduce neoplastic cell proliferation and viability or else make no difference. Invasiveness potential (appraised by cell migration assays and/or differential gene expression) is equivocal. PBM does not induce dysplastic change in healthy cells. In vivo tumor models yield varied results with no clear pattern emerging. There are no relevant clinical trial data linking PBM with any significant adverse events, including the finding of a new or recurrent malignancy. Current clinical and preclinical evidence suggests that PBM is oncologically safe for skin rejuvenation, and there is no evidence to support the proposition that it should be avoided by patients who have previously undergone treatment for cancer.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

How to read a review: what to check before relying on this kind of research.

Terms in this paper: Photobiomodulation, Systematic review, Light-emitting diode. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies